HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

NCT05667714 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled HH-120 Aerosol in Healthy Volunteers

NCT05116865 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

NCT05758519 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia

NCT04679350 ·Status: TERMINATED ·Phase: PHASE2

Intranasal INNA-051 for Prevention of COVID-19 in Adults

NCT05118763 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

NCT04379492 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia

NCT04676971 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

NCT05689203 ·Status: UNKNOWN ·Phase: PHASE2

Use of a Hypochlorous Acid Spray Solution in the Treatment of COVID-19 Patients : COVICONTROL Study .

NCT05862480 ·Status: UNKNOWN ·Phase: NA

Study of HS-10517 in Chinese Adult Participants

NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2

To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold

NCT03005067 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

NCT06574503 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19

NCT04463420 ·Status: UNKNOWN ·Phase: NA

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

NCT04798027 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19

NCT05113810 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

NCT04547140 ·Status: TERMINATED ·Phase: PHASE2

Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts

NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

NCT04421508 ·Status: TERMINATED ·Phase: PHASE3

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

NCT06573008 ·Status: RECRUITING ·Phase: PHASE3

Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray

NCT05437029 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting

NCT04396106 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19

NCT05184218 ·Status: TERMINATED ·Phase: PHASE1

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

NCT05195749 ·Status: TERMINATED ·Phase: PHASE2

HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients

NCT04986176 ·Status: UNKNOWN ·Phase: PHASE3